185 related articles for article (PubMed ID: 22208048)
1. [Palliative pain relief treatment for multiple bone metastases by strontium-89].
Nishio M
Nihon Rinsho; 2011 Jun; 69 Suppl 5():581-5. PubMed ID: 22208048
[No Abstract] [Full Text] [Related]
2. [89-Strontium for painful osteoblastic metastases].
Golan H; Ratz D
Harefuah; 1995 May; 128(10):650-4. PubMed ID: 7541384
[No Abstract] [Full Text] [Related]
3. Strontium-89 (Metastron) versus external beam radiotherapy in patients with painful bone metastases secondary to prostatic cancer: preliminary report of a multicenter trial. UK Metastron Investigators Group.
Bolger JJ; Dearnaley DP; Kirk D; Lewington VJ; Mason MD; Quilty PM; Reed NS; Russell JM; Yardley J
Semin Oncol; 1993 Jun; 20(3 Suppl 2):32-3. PubMed ID: 7684863
[No Abstract] [Full Text] [Related]
4. Treating symptomatic osseous metastases from prostate cancer.
Soffen EM; Greenberg AS; Baumann JC
N J Med; 1997 Nov; 94(11):33-7. PubMed ID: 9385818
[No Abstract] [Full Text] [Related]
5. Strontium-89 therapy for painful osseous metastatic prostate and breast cancer.
Hansen DV; Holmes ER; Catton G; Thorne DA; Chadwick DH; Schmutz DA
Am Fam Physician; 1993 Jun; 47(8):1795-800. PubMed ID: 7684554
[TBL] [Abstract][Full Text] [Related]
6. [The efficacy of therapy using 89Sr-strontium chloride in 200 patients with bone metastases of a prostatic cancer].
Haesner M; Buchali K; Pink V; Lips H
Nuklearmedizin; 1992 Mar; 31(2):48-52. PubMed ID: 1373485
[TBL] [Abstract][Full Text] [Related]
7. [Radioactive substances (32P and 89Sr) in the treatment of pain in bone metastases].
Flamm J; Burkert S
Z Urol Nephrol; 1981 Nov; 74(11):801-6. PubMed ID: 6172913
[TBL] [Abstract][Full Text] [Related]
8. [Strontium-89 for bone metastases from prostate cancer: an update].
Zhao WW; Xie P; Deng HF
Zhonghua Nan Ke Xue; 2010 Mar; 16(3):269-72. PubMed ID: 20369560
[TBL] [Abstract][Full Text] [Related]
9. Disseminated intravascular coagulation in metastatic prostate cancer.
Riddell AJ
J Nucl Med; 1996 Feb; 37(2):401. PubMed ID: 8667086
[No Abstract] [Full Text] [Related]
10. Strontium-89 as an adjuvant to external beam radiation improves pain relief and delays disease progression in advanced prostate cancer: results of a randomized controlled trial.
Porter AT; McEwan AJ
Semin Oncol; 1993 Jun; 20(3 Suppl 2):38-43. PubMed ID: 7684865
[TBL] [Abstract][Full Text] [Related]
11. Strontium 89 in the treatment of bony metastases.
Porter AT; Ben-Josef E
Important Adv Oncol; 1995; ():87-94. PubMed ID: 7545646
[No Abstract] [Full Text] [Related]
12. Dose estimation in strontium-89 radiotherapy of metastatic prostatic carcinoma.
Breen SL; Powe JE; Porter AT
J Nucl Med; 1992 Jul; 33(7):1316-23. PubMed ID: 1613572
[TBL] [Abstract][Full Text] [Related]
13. Bone pain palliation with 85Sr therapy.
Giammarile F; Mognetti T; Blondet C; Desuzinges C; Chauvot P
J Nucl Med; 1999 Apr; 40(4):585-90. PubMed ID: 10210217
[TBL] [Abstract][Full Text] [Related]
14. Radioactive strontium-89 for painful bone metastases.
Med Lett Drugs Ther; 1993 Oct; 35(908):102. PubMed ID: 7692227
[No Abstract] [Full Text] [Related]
15. [Therapeutic efficacy of strontium-89-chloride for bone metastatic tumors without bone pain].
Ouyang W; Liu JH; Liu WY
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Mar; 27(3):390-1. PubMed ID: 17426002
[TBL] [Abstract][Full Text] [Related]
16. Systemic radionuclide therapy of bone metastases with strontium-89.
Porter AT; Davis LP
Oncology (Williston Park); 1994 Feb; 8(2):93-6; discussion 96, 99-101. PubMed ID: 8167090
[TBL] [Abstract][Full Text] [Related]
17. Question of the month--January 1995. What is the optimal dose of 89Sr for bone pain palliation?
Khader Z
Nucl Med Commun; 1995 Apr; 16(4):306. PubMed ID: 7542759
[No Abstract] [Full Text] [Related]
18. The treatment of osseous metastases of hormone-refractory prostate cancer with external beam radiotherapy and Strontium-89.
De Ruysscher D; Spaas P; Specenier P
Acta Urol Belg; 1996 Sep; 64(3):13-9. PubMed ID: 8946776
[TBL] [Abstract][Full Text] [Related]
19. The treatment of painful osteoblastic metastases: what can we expect from nuclear oncology?
Silberstein EB
J Nucl Med; 1994 Dec; 35(12):1994-5. PubMed ID: 7527457
[No Abstract] [Full Text] [Related]
20. [Use of strontium-89 in the analgesic treatment of cancer patients with bone metastases].
Baranauskas Z; Valuckas K; Aleknavicius E; Jankevicius F; Burneckis A; Paviloniene I
Medicina (Kaunas); 2006; 42(1):11-4. PubMed ID: 16467608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
